Delafloxacin meglumine
Baxdela is a prescription antibiotic tablet containing delafloxacin meglumine, used to treat certain bacterial infections. It belongs to the fluoroquinolone class and is taken orally. Manufactured by Melinta Therapeutics, LLC. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Baxdela is a prescription antibiotic tablet containing delafloxacin meglumine, used to treat certain bacterial infections. It belongs to the fluoroquinolone class and is taken orally. Manufactured by Melinta Therapeutics, LLC. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Delafloxacin meglumine", "mediaType": "text/html", "description": " Access the FDA dataset for Delafloxacin meglumine — ANDA 208610 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208610" } ] |
| identifier | ANDA208610 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "drug-information", "drug-manufacturers", "drug-safety", "pharmaceuticals" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Delafloxacin meglumine |
